Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$533K Buy
1,472
+464
+46% +$159K 0.12% 206
2026
Q1
$355K Buy
1,008
+121
+14% +$43.1K 0.09% 261
2025
Q4
$290K Sell
887
-401
-31% -$127K 0.08% 272
2025
Q3
$363K Buy
1,288
+171
+15% +$49.6K 0.08% 226
2025
Q2
$312K Buy
1,117
+305
+38% +$86.4K 0.09% 237
2025
Q1
$256K Sell
812
-171
-17% -$50.5K 0.07% 254
2024
Q4
$256K Buy
983
+162
+20% +$48.1K 0.05% 294
2024
Q3
$265K Sell
821
-684
-45% -$224K 0.1% 204
2024
Q2
$470K Sell
1,505
-1,829
-55% -$537K 0.14% 158
2024
Q1
$948K Buy
3,334
+4
+0.1% +$1.17K 0.19% 126
2023
Q4
$959K Buy
3,330
+636
+24% +$173K 0.19% 119
2023
Q3
$729K Buy
2,694
+1,439
+115% +$359K 0.15% 154
2023
Q2
$279K Buy
+1,255
New +$291K 0.08% 252
2023
Q1
Sell
-3,212
Closed -$844K 512
2022
Q4
$844K Sell
3,212
-138
-4% -$37K 0.2% 123
2022
Q3
$755K Buy
3,350
+1,901
+131% +$461K 0.19% 123
2022
Q2
$352K Buy
1,449
+430
+42% +$105K 0.09% 232
2022
Q1
$246K Buy
+1,019
New +$234K 0.05% 306

Other funds holding AMGN

World Equity Group's AMGN Position: Q2 2026 in Review

World Equity Group increased its Amgen (AMGN) stake by 46% in Q2 2026, buying an estimated $159K and bringing the position to 1,472 shares worth $533K. The position accounts for 0.12% of the portfolio, ranked #206.

World Equity Group first reported a position in AMGN in Q1 2022 and has held it in 17 quarters since. The position peaked at $959K in Q4 2023. 1,447 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • World Equity Group held 1,472 shares of Amgen worth $533K as of Q2 2026.
  • World Equity Group bought 464 Amgen shares in Q2 2026, an estimated $159K.
  • Amgen made up 0.12% of World Equity Group's portfolio in Q2 2026, its #206 holding.
  • World Equity Group first reported a position in Amgen in Q1 2022 and has held it in 17 quarters since.
  • World Equity Group's Amgen position peaked at $959K in Q4 2023.
  • 1,447 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on World Equity Group's 13F filing for Q2 2026, filed 9 Jul 2026.